SBWire

Animal and plant-based food items are ideal sources of vitamins and minerals. People nowadays are reducing their consumption of processed food, and prefer the healthy ones. In addition to eating healthy food, an increasing number of people are also taking nutritional supplements such as fish oil.

The media has recently been abuzz with the name Adam Finnieston. MR Finnieston has recently achieved much recognition for his ingenious prosthetic orthotic designs. It has been widely acclaimed for helping so many of the injured individuals to be able to lead a full and satisfactory life with an innovative on their legs.

ChroMedX Corp. (the "Company") (CSE: CHX, OTC: MNLIF, Frankfurt: EIY2), a developer of in vitro diagnostics and point-of-care testing (POCT) is pleased to report the completion of the HemoPalmTM System Prototype Cartridge.

Future Market Insights (FMI) delivers key insights on the global ABUS market in its upcoming outlook titled, "Automated Breast Ultrasound System (ABUS) Market: Global Industry Analysis and Opportunity Assessment, 2015 - 2025". In terms of value, the global ABUS market is projected to register a healthy CAGR of 8.1% during the forecast period due to various factors, regarding which, FMI offers vital insights in detail. The global ABUS market is projected to register a CAGR of 8.5% in terms of volume during the forecast period.

The report " Retinal Surgery Devices Market [Equipment Type: Vitrectomy Packs, Vitrectomy Machines, Retinal Laser Equipment, Microscopic Illumination Equipment, Surgical Instruments (Cannulas, Forceps, Cutters, Cryoprobes, etc.) & Others (Retinal Tamponades, Sclera Buckle, etc.); Applications: Diabetic Retinopathy, Retinal Detachment, Epiretinal Membrane, Macular Hole & Others (Eye infections and Eye injuries)] - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 " has been added to the repository of Market Research Reports Search Engine (MRRSE).

Market Research Reports Search Engine (MRRSE) has recently announced the addition of a new market research report to its comprehensive collection of research studies. The research report is titled, "Market Snapshot: Transcatheter Heart Valve 2007 to 2020 – Europe", which is a publication of Global Business intelligence (GBI).

Market Research Reports Search Engine (MRRSE) has announced the addition of a new research report based on the global diagnostic imaging devices market. The report states that the global market is expected to expand moderately at a CAGR of 5.2% between 2014 and 2020 and reach a value of US$35,793.4 million by 2020. The market for diagnostic imaging devices amounted to US$26,477.1 million in 2014.

Advanced dressings have steadily replaced traditional bandages and gauze materials in the treatment of a variety of wound indications, such as trauma wounds, burns, and chronic ulcerations. As fluid management, infection control, and physical protection become increasingly critical in wound healing, advanced dressings enjoy a greater role in standard therapy.

Advanced wound dressings are used to treat a variety of acute wounds, such as burns, cuts, lacerations and abrasions, chronic wounds, such as a diabetic foot ulcers, pressure ulcers and leg ulcers, and surgical wounds sustained during various procedures.

The report studies the global Medical Tablet market from ground up, basing the introduction at industry-specific definitions of key elements of the market and then progressing to the details regarding the structure of the industry chain, analysis of policies and regulatory structure, and recent developments in the Medical Tablet market.

Xhale Assurance, Inc. today announced it has received CE Mark approval of its Nasal Alar SpO2 Sensor for clinical use in CE countries. A CE Mark verifies the Assurance® Nasal Alar SpO2™ Sensor has met all applicable directives of the European Commission (EC) and subsequently the laws and regulations of the European Union (EU) member states and therefore can be commercialized within the 30-nation EEA and Switzerland.

LabStyle Innovations Corp., developer of the Dario™ Diabetes Management Solution, today announced the Company will present at the Rodman & Renshaw 17th Annual Global Investment Conference on Wednesday, September 9, 2015. The conference will take place from September 8-10, 2015 at the St. Regis Hotel in New York City. Chairman and Chief Executive Officer Erez Raphael and Chief Financial Officer Zvi Ben-David will present at 4:15pm ET in the Fountainebleau Foyer, 2nd floor. Investors interested in a one-on-one meeting with management, may contact Rodman & Renshaw or contact LabStyle directly regarding scheduling a meeting.

Snoring has been found to have a negative impact on the person as well as his or her partner. It is said to cause a disturbed sleep pattern and in order to prevent the same, Amazon has come up with a new product. This is available at http://www.amztk.com/stopsnore at a price of $15.70 and has been manufactured by BGS Global. It is said to be an ideal solution as the twin pack is available in 2 different sizes. All those who are looking for such a product can consider the aforementioned URL.

According to a new market report published by Transparency Market Research Bone Grafts and Substitutes Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2015 - 2023, the global bone grafts and substitutes market was valued at USD 2.35 billion in 2014 and is anticipated to expand at a CAGR of 4.5% from 2015 to 2023 to reach USD 3.48 billion in 2023.

Implantable medical devices are artificial implants used to replace, augment, or repair damaged tissues or organs. They are used in a wide range of applications including cosmetic, spinal, cardiovascular, ophthalmic, and neuro-stimulator implantation surgeries. These implants are made of different materials such as polymers, metals, ceramics, and biologics.

The risk of healthcare-associated infections continues to be a challenge and a major focus for hospitals and medical facilities across the US. Recently, studies have shown that one of the places where potentially dangerous viruses and bacteria are likely to quickly and frequently accumulate is on the privacy curtains of hospitals, putting the patients at risk. The ImageFIRST Detroit location has announced it is now offering a new Cubical Curtain Program to help hospitals prevent the spread of potentially dangerous bacteria, a program also available through many other of the company's other locations nationwide.

ChroMedX Corp, a developer of in vitro diagnostics and point-of-care testing (POCT) is pleased to announce the engagement of technology development and prototyping firm Polygenesis Corporation to continue the development of the HemoPalm biosensor array, a fundamental component of the HemoPalm system.

ChroMedX Corp(the "Company"), a developer of in vitro diagnostics and point-of-care testing (POCT) technologies is pleased to announce the filing of a PCT (Patent Cooperation Treaty) Patent Application pertaining to the HemoPalm(TM) Cartridge and Analyzer system called "Joint Spectroscopic and Biosensor System for Point-of-Care Testing" (PCT/CA2015/050455).

Cryogenic freezers are technologies used in storing DNA, human tissues, blood products, stem cells, umbilical cord blood, oocytes and embryos, and other sensitive medical and biological specimens. They rely on specialized mechanical systems or liquid nitrogen to operate. These freezers minimize the level of deterioration and provide maximum viability of samples as they have a temperature of approximately -150degC. At this temperature, the metabolic activities and molecular motion of water cease, putting cells in suspended animation and making it suitable for their pristine preservation.

LabStyle Innovations Corp, developer of the Dario™ Diabetes Management Solution, today announced it recently closed a round of funding totaling approximately $2.5 million. Funds will be used to support the global rollout and initial U.S. commercial launch of the Dario, a mobile, cloud-based, diabetes management solution that includes novel software applications combined with a stylish, 'all-in-one,' pocket-sized, blood glucose monitoring device, and for working capital purposes. The Dario recently launched in Canada with reimbursement through a majority of medical plans and the U.S. Food and Drug Administration's clearance is anticipated in the coming months.

BestSnoringMouthpieces.org is a newly launched website that has been developed for the sole purpose of assisting readers in the selection of the best anti snoring mouthpieces. The website was established noting that buyers are often confused about snoring mouthpieces and other devices due to the wide variety of options currently available on the market. With this in mind, the reviewers of Best Snoring Mouthpieces have taken the painstaking task of researching and testing different products to write informative, in depth and comprehensive snoring mouthpiece reviews that make their readers choices simpler.

Arrhythmia is a condition resulting in an abnormal heartbeat, which occurs due to changes in electrical impulses. The electrical impulses can either be too fast or too slow, resulting in sudden cardiac arrest. Cardiac arrhythmia is one of the leading causes of premature death and is characterized by the abrupt loss of heart function. Cardiac dysfunction results in the inhibition of blood flow to the brain and other vital organs.

Fast Market Research announces the availability of Technavio's new report "PTCA Balloon Catheter Market in China 2015-2019" on their comprehensive research portal.

At ImageFIRST - South LA, and other branches of the healthcare laundry services company across the U.S., employees are encouraged to volunteer in the communities in which they live, and are provided with plenty of opportunities to do so through ImageFIRST's relationships with well-known charitable organizations. On June 27, 2015, members of the ImageFIRST South LA team took part in an event called "Not On My Watch" to raise awareness of suicide by military members, which was timed to correspond with National Post-Traumatic Stress Disorder (PTSD) Awareness Week.

LabStyle Innovations Corp., developer of the Dario™ Diabetes Management Solution, today announced that in conjunction with its Australian distributor, uHealth, the Company is exhibiting at the Australian Diabetes Society (ADS) and Australian Diabetes Educators Association's (ADEA) 2015 Annual Scientific Meeting and Exhibition in Adelaide, Australia. From Wednesday, August 26th through Friday, August 28th, at Booth #9 LabStyle will showcase the Dario Diabetes Management System. The Dario platform is a next generation technology that digitizes every testing event through a miniature meter powered directly by a smartphone via the audio jack turning an iOs or Android smartphone into a cloud-linked meter. In addition to having received regulatory approval in Australia, the Dario is CE marked in Europe and approved in Canada.